AAAAAA

   
Results: 1-25 | 26-31 |
Results: 26-31/31

Authors: Nebert, DW Ingelman-Sundberg, M Daly, AK
Citation: Dw. Nebert et al., Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues, DRUG METAB, 31(2), 1999, pp. 467-487

Authors: Nebert, DW
Citation: Dw. Nebert, Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?, CLIN GENET, 56(4), 1999, pp. 247-258

Authors: Shertzer, HG Puga, A Chang, CY Smith, P Nebert, DW Setchell, KDR Dalton, TP
Citation: Hg. Shertzer et al., Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones, CHEM-BIO IN, 123(1), 1999, pp. 31-49

Authors: Dey, A Jones, JE Nebert, DW
Citation: A. Dey et al., Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization, BIOCH PHARM, 58(3), 1999, pp. 525-537

Authors: Tonge, RP Kelly, EJ Bruschi, SA Kalhorn, T Eaton, DL Nebert, DW Nelson, SD
Citation: Rp. Tonge et al., Role of CYP1A2 in the hepatotoxicity of acetaminophen: Investigations using Cyp1a2 null mice, TOX APPL PH, 153(1), 1998, pp. 102-108

Authors: Shertzer, HG Nebert, DW Puga, A Ary, M Sonntag, D Dixon, K Robinson, LJ Cianciolo, E Dalton, TP
Citation: Hg. Shertzer et al., Dioxin causes a sustained oxidative stress response in the mouse, BIOC BIOP R, 253(1), 1998, pp. 44-48
Risultati: 1-25 | 26-31 |